Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy
MR Lahimchi, F Maroufi, A Maali - Cellular Reprogramming, 2023 - liebertpub.com
Chimeric antigen receptor (CAR) T cell therapy is a promising cell-based immunotherapy
applicable to various cancers. High cost of production, immune rejection, heterogeneity of …
applicable to various cancers. High cost of production, immune rejection, heterogeneity of …